Health Psychology Department, Calitè Research Group, Miguel Hernández University, Elche, Spain.
Calitè Research Group, Miguel Hernández University, Elche, Spain.
Orphanet J Rare Dis. 2021 Feb 5;16(1):67. doi: 10.1186/s13023-021-01700-z.
To measure the experience of the person having a rare disease in order to identify objectives for optimal care in the health care received by these patients.
A cross-sectional study was conducted in Spain involving patients associated with the Spanish Rare Diseases Federation [Federación Española de Enfermedades Raras] (FEDER). A modified version of the PREM IEXPAC [Instrumento para evaluar la Experiencia del Paciente Crónico] instrument was used (IEXPAC-rare-diseases). Scores ranged between 0 (worst experience) and 10 (best experience).
A total of 261 caregivers (in the case of paediatric population) and patients with rare diseases (response rate 54.4%) replied. 232 (88.9%) were adult patients and 29 (11.1%) caregivers of minor patients. Most males, 227 (87%), with an average age of 38 (SD 13.6) years. The mean time since confirmation of diagnosis was 7.8 (SD 8.0) years. The score in this PREM was 3.5 points out to 10 (95%CI 3.2-3.8, SD 2.0). Caregivers of paediatric patients scored higher, except for coordination of social and healthcare services.
There are wide and important areas for improvement in the care of patients with rare diseases. This study involves a first assesment of the experience of patients with rare diseases in Spain.
衡量罕见病患者的体验,以便确定为这些患者提供的医疗服务的最佳目标。
在西班牙进行了一项横断面研究,涉及与西班牙罕见病联合会(Federación Española de Enfermedades Raras)相关的患者。使用了 PREM IEXPAC(慢性病患者评估工具)的改良版(IEXPAC-rare-diseases)。评分范围为 0(最差体验)至 10(最佳体验)。
共有 261 名罕见病患者(若为儿科患者,则为其照顾者)(应答率为 54.4%)回复了调查。232 名(88.9%)为成年患者,29 名(11.1%)为未成年患者的照顾者。大多数为男性,227 名(87%),平均年龄为 38 岁(标准差 13.6)。确诊后平均时间为 7.8 年(标准差 8.0)。PREM 评分中得分为 3.5 分(95%CI 3.2-3.8,标准差 2.0)。儿科患者的照顾者评分较高,但协调社会和医疗保健服务除外。
在罕见病患者的护理方面有广泛且重要的改进领域。本研究首次评估了西班牙罕见病患者的体验。